

House Committee Examines Bills That Would Make Drug Pricing More Transparent

Minnesota Legislature Approves First Ever Bill Regulating Pharmacy Benefit Managers

GlaxoSmithKline is the Perfect Example of a Company Engaging in Anti-Competitive Behavior and Price


Judge Picks Six Witnesses, Sets Hearing Date to Hear Criticisms of CVS-Aetna Merger


FTC Commissioner Rohit Chopra Says Rebate Walls and PBMs Need to Be Looked At and Hurt Competition

New Bill Would Require the FTC to Investigate Competition in the PBM Market


Senate Judiciary Committee Examines Patent Abuse, Anticompetitive Behavior That Contributes to Risin

Consumer Groups Submit Letter to Senate Leaders in Support of the CREATES Act


Ohio State Representatives Propose Stricter Oversight of PBMs and Medicaid

States Are Taking Aggressive Steps To Lower Drug Prices By Regulating Drug Companies and PBMs